ArticleBiomedical optics express2026
Accelerated immunostaining of thick biological tissues using bidirectional electric fields with reversible deformation.
Article in Biomedical optics express, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Immunostaining of thick biological tissues is often limited by slow antibody transport, resulting in long processing times and depth-dependent labeling. We describe an automated immunostaining approach based on an alternating bidirectional electric field, termed ARDEI, that improves labeling performance in millimeter-scale tissues. Under the applied electric-field conditions, tissue samples undergo reversible cyclic deformation, which may contribute to antibody redistribution by transiently altering tissue geometry. Using ARDEI, 1000 μm-thick mouse brain sections were labeled within 2.5 h, with improved signal penetration and spatial uniformity compared with passive diffusion and unidirectional electric-field staining under time-matched conditions. The system operates at 40 V under temperature-controlled conditions, minimizing thermal and structural perturbation. ARDEI supports three-dimensional imaging of neuronal and glial structures and can be applied to SHANEL-pretreated human brain tissue, where improved labeling uniformity was observed in 1000 μm-thick sections within 4 h. Under the tested conditions, repeated deformation cycles did not produce detectable structural distortion or signal degradation. These results show that ARDEI improves thick-tissue immunostaining performance and are consistent with a contribution from coupled electric-field-assisted transport and reversible tissue deformation. ARDEI provides a practical approach that can be integrated with existing optical imaging workflows for volumetric tissue analysis.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.